Jounce Therapeutics (JNCE) Reports Q2 Loss of $0.14/Share

Go back to Jounce Therapeutics (JNCE) Reports Q2 Loss of $0.14/Share
(NASDAQ: JNCE) Delayed: 1.88 --0 (-0%)
Previous Close $1.88    52 Week High
Open $13.36    52 Week Low
Day High $1.88    P/E N/A 
Day Low $1.88    EPS
Volume 325,016